IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vistagen Therapeutics Inc (VTGNUSD)

CUSIP: 92840H202 | X2 | 234 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

TCG Crossover Management, LLC2,676,580
1.0% of portfolio›$9.3M
StyleTurnoverLocationFiled
TCG Crossover Management, LLC
2,676,580$9.3M1.0%GrowthMediumPalo Alto, CA2024-08-14